Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
milehighcompounds.is
Samples
Passed
Failed
Trust score updated: May 28, 2026 · 98% pass rate
Composite score based on 63 COAs attributed to this vendor.
Mean HPLC purity across published COAs
Per-peptide coverage of identity / endotoxin / microbial / heavy-metals / net-content panels
Lab corroboration tier — confirmed via public verify portal (90), presumptive trusted lab (85), lab resolved but unverified (75), or no lab attribution (50)
Inverse of CoaFlag count (lot collisions, hash collisions, etc.)
Composite of 63 COAs attributed to this vendor. Last recomputed 2026-05-28.
| Date | Peptide | Test | Result | Purity | Lab | Notes |
|---|---|---|---|---|---|---|
| May 13, 2026 | Acetric Acid | Identity & safety panels | PASS | -- | Vanguard Laboratory | Lot ACE-010-MH-01 · Report V260501-19 001 |
| Mar 24, 2026 | AOD-9604 | HPLC purity | PASS | 99.957% | Kovera Labs | Lot AOD-005-MH-02 · Report KVR-2026-73D672 |
| Mar 22, 2026 | Tesamorelin | HPLC purity | PASS | 99.928% | Kovera Labs |
We are continuously testing more products. Scores update with each new result.
Read our scoring methodology →Trust scores are computed from indexed Certificates of Analysis — vendor-published, and lab-confirmed where a lab copy verifies them — using a fixed, versioned methodology (v13). They are not based on independent blind-purchase testing, and no vendor can pay for placement or a higher score. How we score · How we make money
New domain (-0.06), No physical address (-0.03), No business entity (-0.03), Clean presence (0.03), Lab-confirmed (0.02)
Sources: RDAP/WHOIS for domain data, Twilio Lookup for phone classification, Google Places for address verification. Crawl runs weekly. Signals are independent of vendor-supplied data.
| Lot TES-010-MH-03 · Report KVR-2026-8E1FA7 |
| Mar 21, 2026 | Klow | HPLC purity | PASS | 99.688% | Kovera Labs | Lot KLW-080-MH-02 · Report KVR-2026-762659 |
| Mar 21, 2026 | PT-141 | HPLC purity | PASS | 99.927% | Kovera Labs | Lot PT1-010-MH-02 · Report KVR-2026-C4CF92 |
| Mar 21, 2026 | Glow | HPLC purity | PASS | 99.739% | Kovera Labs | Lot GLW-070-MH-02 · Report KVR-2026-43E44C |
| Mar 20, 2026 | CJC-1295 (No DAC)/Ipamorelin | HPLC purity | PASS | 99.872% | Kovera Labs | Lot CIB-010-MH-01 · Report KVR-2026-C194BA |
| Mar 20, 2026 | Cagrilintide | HPLC purity | PASS | 99.95% | Kovera Labs | Lot CAG-010-MH-02 · Report KVR-2026-DDD192 |
| Mar 20, 2026 | TB-500 (Thymosin B4) | HPLC purity | PASS | 99.919% | Kovera Labs | Lot TB5-010-MH-04 · Report KVR-2026-A9A50B |
| Mar 19, 2026 | Melanotan-2 | HPLC purity | PASS | 99.971% | Kovera Labs | Lot MLN-010-MH-01 · Report KVR-2026-E60DA5 |
| Mar 18, 2026 | GLP-2 TRZ | HPLC purity | PASS | 99.929% | Kovera Labs | Lot GLP-260-MH-04 · Report KVR-2026-195519 |
| Mar 18, 2026 | Glutathion | HPLC purity | PASS | 99.907% | Kovera Labs | Lot GLU-150-MH-01 · Report KVR-2026-91DC1D |
| Mar 18, 2026 | MOTS-c | HPLC purity | PASS | 99.736% | Kovera Labs | Lot MOT-010-MH-03 · Report KVR-2026-4DAB54 |
| Mar 14, 2026 | Pinealon | HPLC purity | PASS | 99.907% | Kovera Labs | Lot PNL-010-MH-01 · Report KVR-2026-1A48AC |
| Mar 14, 2026 | 5-Amino-1MQ | HPLC purity | PASS | 99.944% | Kovera Labs | Lot AMN-050-MH-01 · Report KVR-2026-899648 |
| Mar 14, 2026 | Oxytocin | HPLC purity | PASS | 99.928% | Kovera Labs | Lot OXN-010-MH-01 · Report KVR-2026-C69C73 |
| Mar 12, 2026 | TB-500 | HPLC purity | PASS | 99.08% | Vanguard Laboratory | Lot TB5-010-MH-03 · Report V260220-12001 |
| Mar 12, 2026 | SS-31 | HPLC purity | PASS | 99.04% | Vanguard Laboratory | Lot SS3-010-MH-04 · Report V260220-12002 |
| Mar 11, 2026 | BPC-157 | Identity & safety panels | PASS | -- | Vanguard Laboratory | Lot BPC-500-MH-02 · Report V260218-22001 |
| Mar 10, 2026 | BPC-157/TB-500 | HPLC purity | PASS | 99.936% | Kovera Labs | Lot WLV-020-MH-02 · Report KVR-2026-F41ED4 |
| Mar 9, 2026 | GHK-Cu | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot GHK-050-MH-03 · Report V260218-21001 |
| Mar 9, 2026 | MHC-3RT | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot GLP-305-MH-01 · Report V260218-21002 |
| Mar 4, 2026 | GHK-Cu | Identity & safety panels | PASS | -- | Vanguard Laboratory | Lot GHK-002-MH-01 · Report V260218-22003 |
| Mar 2, 2026 | Tesofensine | Identity & safety panels | PASS | -- | Vanguard Laboratory | Lot TSF-500-MH-02 · Report V260218-22005 |
| Mar 1, 2026 | BPC-157/KPV | Identity & safety panels | PASS | -- | Vanguard Laboratory | Lot KPC-001-MH-01 · Report V260218-22001 |
| Mar 1, 2026 | MHC-3RT | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot GLP-320-MH-01 · Report V260218-21003 |
| Feb 27, 2026 | Tesamorelin | HPLC purity | PASS | 99.938% | Kovera Labs | Lot TES-010-MH-02 · Report KVR-2026-3B193F |
| Feb 26, 2026 | NAD+ | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot NAD-500-MH-04 · Report V260218-21004 |
| Feb 26, 2026 | Melanotan-1 | HPLC purity | PASS | 99.981% | Kovera Labs | Lot MT1-010-MH-01 · Report KVR-2026-151E2B |
| Feb 18, 2026 | Tesamorelin/Ipamorelin | HPLC purity | PASS | 99.04% | Vanguard Laboratory | Lot TIB-013-MH-01 · Report V260218-13001 |
| Feb 13, 2026 | IGF-1 LR3 | HPLC purity | PASS | 98.87% | Vanguard Laboratory | Lot IGF-001-MH-02 · Report V260210-9 001 |
| Feb 10, 2026 | Semax | HPLC purity | PASS | 99.5% | Vanguard Laboratory | Lot SMX-010-MH-04 · Report V260126-9 001 |
| Feb 7, 2026 | MHC-3 RT | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot GLP-330-MH-04 · Report V260120-6 002 |
| Feb 7, 2026 | Semax/Selank | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot SSB-020-MH-01 · Report V260120-6 003 |
| Jan 20, 2026 | MOTS-c | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot MOT-010-MH-02 · Report V260109-19 001 |
| Jan 20, 2026 | KPV | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot KPV-010-MH-02 · Report V260105-17 001 |
| Jan 2, 2026 | VIP | HPLC purity | PASS | 99.274% | Janoshik Analytical | Lot VIP-010-MH-01 · Report 95985 |
| Dec 18, 2025 | Testagen | HPLC purity | PASS | 96.762% | Chromate | Lot TST-025-MH-01 · Report 30971 |
| Dec 18, 2025 | Cartalax | HPLC purity | PASS | 99.913% | Chromate | Lot CAR-025-MH-01 · Report 30651 |
| Dec 18, 2025 | Prostamax | HPLC purity | PASS | 98.692% | Chromate | Lot PMX-025-MH-01 · Report 30649 |
| Dec 18, 2025 | Thymogen | HPLC purity | PASS | 99.413% | Chromate | Lot THY-025-MH-01 · Report 30648 |
| Dec 18, 2025 | BPC-157 | HPLC purity | PASS | 99.8% | Vanguard Laboratory | Lot BPC-010-MH-03 · Report V251212-17 001 |
| Dec 18, 2025 | Cardiogen | HPLC purity | PASS | 98.384% | Chromate | Lot CRD-025-MH-01 · Report 30652 |
| Dec 13, 2025 | NAD+ | HPLC purity | FAIL | 93.706% | Chromate | Lot NAD-500-MH-03 · Report 30337 |
| Dec 12, 2025 | ARA290 | HPLC purity | PASS | 99.597% | Chromate | Lot ARA-012-MH-01 · Report 30433 |
| Dec 11, 2025 | Lipo-C | Identity & safety panels | PASS | -- | Chromate | Lot LIP-010-MH-01 · Report 30225 |
| Dec 9, 2025 | Wolverine 2.0 30mg | HPLC purity | PASS | 99.621% | Chromate | Lot WL2-030-MH-01 · Report 31032 |
| Nov 29, 2025 | Selank | HPLC purity | PASS | 99.959% | Chromate | Lot SLK-010-MH-02 · Report 30901 |
| Nov 13, 2025 | Cyanocobalamin | HPLC purity | PASS | 99.221% | Chromate | Lot VIT-010-MH-01 · Report 29512 |
| Nov 6, 2025 | SNAP-8 | HPLC purity | PASS | 98.683% | Chromate | Lot SNA-010-MH-01 · Report 29380 |